NCT05681286

Brief Summary

we aimed to compare C-reactive protein to serum albumin ( CAR) level of the T2DM patients with DN to those T2DM without DN

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
70

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Aug 2023

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 25, 2022

Completed
18 days until next milestone

First Posted

Study publicly available on registry

January 12, 2023

Completed
7 months until next milestone

Study Start

First participant enrolled

August 4, 2023

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 4, 2024

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

August 4, 2025

Completed
Last Updated

January 31, 2023

Status Verified

December 1, 2022

Enrollment Period

1 year

First QC Date

December 25, 2022

Last Update Submit

January 28, 2023

Conditions

Type 2 DM /Diabetic Nephropathy

Outcome Measures

Primary Outcomes (1)

  • C-reactive protein to serum albumin ratio in type 2diabetic patients with diabetic nephropathy

    comparison between CAR level è type 2 diabetic nephropathy patient and those without nephropathy

    Baseline

Eligibility Criteria

Sexall
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

type 2 DM patients

You may not qualify if:

  • Type 1 diabetes is , patient t with liver cirrhosis, patient with active infection ,pregnant women,patients with cancer

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Officials

  • Salah Argoon

    Assuit u

    STUDY CHAIR

  • Alshaimaa sayed

    Assiut University

    STUDY CHAIR

Central Study Contacts

Shymaa Shahhat, Master

CONTACT

01024302315shoshahhat@yahoo.com

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Investigator

Study Record Dates

First Submitted

December 25, 2022

First Posted

January 12, 2023

Study Start

August 4, 2023

Primary Completion

August 4, 2024

Study Completion

August 4, 2025

Last Updated

January 31, 2023

Record last verified: 2022-12